David H. Kirske
2017
In 2017, David H. Kirske earned a total compensation of $958K as Executive Vice President, Chief Financial Officer at CTI BioPharma.
Compensation breakdown
| Bonus | $42,971 |
|---|---|
| Option Awards | $740,708 |
| Salary | $122,776 |
| Other | $51,538 |
| Total | $957,993 |
Kirske received $740.7K in option awards, accounting for 77% of the total pay in 2017.
Kirske also received $43K in bonus, $122.8K in salary and $51.5K in other compensation.
Rankings
In 2017, David H. Kirske's compensation ranked 9,173rd out of 14,666 executives tracked by ExecPay. In other words, Kirske earned more than 37.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,173 out of 14,666 | 38th |
Division Manufacturing | 3,525 out of 5,768 | 39th |
Major group Chemicals And Allied Products | 1,206 out of 2,074 | 42nd |
Industry group Drugs | 967 out of 1,730 | 44th |
Industry Pharmaceutical Preparations | 758 out of 1,329 | 43rd |
Source: SEC filing on March 30, 2018.
Kirske's colleagues
We found six more compensation records of executives who worked with David H. Kirske at CTI BioPharma in 2017.
2017
Adam Craig
CTI BioPharma
Chief Executive Officer
2017
Bruce Seeley
CTI BioPharma
Chief Operating Officer
2017
Jack Singer
CTI BioPharma
Chief Scientific Officer
2017
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
2017
Matthew Plunkett
CTI BioPharma
Former Executive Vice President, Chief Business Officer
2017
Richard Love
CTI BioPharma